How much does Trientine cost in the United States?

Trientine(Trientine) is an important therapeutic drug for the treatment of Wilson's disease, and its pricing in the U.S. market has always remained at a high level. Since it is a relatively scarce specialty drug as a copper chelator, and Wilson's disease is a rare disease, the patient population is limited, which makes the drug's research and development, production and supply chain costs high, so its selling price is often much higher than that of ordinary chronic disease drugs. In the United States, trientine is mostly sold in the form of brand-name drugs, usually in 200 mg capsules. Drug prices are often affected by market fluctuations, insurance coverage, and manufacturer pricing strategies.

Judging from the current drug prices, the selling price of trientine in the US and European markets is in a relatively high range. Among the German version of the original trientine drug, which has been on the market for many years and has a stable supply, the price of 200mg*100 tablets usually exceeds 40,000 yuan. Due to exchange rate changes, regional differences, import logistics costs and drug policy adjustments, the above prices may fluctuate to a certain extent, but overall they are still in the category of high-priced drugs. For patients with Wilson's disease who require long-term maintenance treatment, such prices mean a relatively heavy financial burden. Therefore, patients in many countries mainly rely on medical insurance or special subsidies for rare diseases to reduce the burden.

The reason for the high drug prices in the U.S. market is mainly related to the patent protection of drugs, R&D investment, market dominance of original research manufacturers, and relatively limited production scale. Trientine is a prescription drug in the United States and can only be purchased through regular hospital pharmacies, and it usually must be taken long-term under the guidance of a doctor. Although the U.S. medical system has an insurance sharing mechanism, the out-of-pocket portion may still be high, so price remains a continued focus for patients.

Despite its higher price, trientine remains one of the important treatment options for Wilson's disease, especially for patients who are intolerant to penicillamine or experience severe adverse reactions. Compared with penicillamine, trientine has lower risks of rash, bone marrow suppression, etc., so it is widely used in international clinical practice.

Reference materials:https://www.cufence.com/